256 related articles for article (PubMed ID: 25573145)
1. Computational identification of multi-omic correlates of anticancer therapeutic response.
Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
[TBL] [Abstract][Full Text] [Related]
2. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection.
Dong Z; Zhang N; Li C; Wang H; Fang Y; Wang J; Zheng X
BMC Cancer; 2015 Jun; 15():489. PubMed ID: 26121976
[TBL] [Abstract][Full Text] [Related]
3. Comparison and validation of genomic predictors for anticancer drug sensitivity.
Papillon-Cavanagh S; De Jay N; Hachem N; Olsen C; Bontempi G; Aerts HJ; Quackenbush J; Haibe-Kains B
J Am Med Inform Assoc; 2013; 20(4):597-602. PubMed ID: 23355484
[TBL] [Abstract][Full Text] [Related]
4. Multitask learning improves prediction of cancer drug sensitivity.
Yuan H; Paskov I; Paskov H; González AJ; Leslie CS
Sci Rep; 2016 Aug; 6():31619. PubMed ID: 27550087
[TBL] [Abstract][Full Text] [Related]
5. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
6. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
[TBL] [Abstract][Full Text] [Related]
7. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
8. Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis.
Brindha GR; Rishiikeshwer BS; Santhi B; Nakendraprasath K; Manikandan R; Gandomi AH
Comput Methods Programs Biomed; 2022 Sep; 224():107027. PubMed ID: 35914385
[TBL] [Abstract][Full Text] [Related]
9. Large-Scale Drug Screens Support Precision Medicine.
Gray JW; Mills GB
Cancer Discov; 2015 Nov; 5(11):1130-2. PubMed ID: 26526695
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced cell viability prediction from LINCS-L1000 through WRFEN-XGBoost algorithm.
Lu J; Chen M; Qin Y
BMC Bioinformatics; 2021 Jan; 22(1):13. PubMed ID: 33407085
[TBL] [Abstract][Full Text] [Related]
11. Predicting anticancer peptides with Chou's pseudo amino acid composition and investigating their mutagenicity via Ames test.
Hajisharifi Z; Piryaiee M; Mohammad Beigi M; Behbahani M; Mohabatkar H
J Theor Biol; 2014 Jan; 341():34-40. PubMed ID: 24035842
[TBL] [Abstract][Full Text] [Related]
12. Computational models for predicting anticancer drug efficacy: A multi linear regression analysis based on molecular, cellular and clinical data of oral squamous cell carcinoma cohort.
Robert BM; Brindha GR; Santhi B; Kanimozhi G; Prasad NR
Comput Methods Programs Biomed; 2019 Sep; 178():105-112. PubMed ID: 31416538
[TBL] [Abstract][Full Text] [Related]
13. Prediction of anti-cancer drug response by kernelized multi-task learning.
Tan M
Artif Intell Med; 2016 Oct; 73():70-77. PubMed ID: 27926382
[TBL] [Abstract][Full Text] [Related]
14. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
[TBL] [Abstract][Full Text] [Related]
15. Screening and evaluation of anticancer agents.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):67-101. PubMed ID: 3283480
[TBL] [Abstract][Full Text] [Related]
16. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
17. DISIS: prediction of drug response through an iterative sure independence screening.
Fang Y; Qin Y; Zhang N; Wang J; Wang H; Zheng X
PLoS One; 2015; 10(3):e0120408. PubMed ID: 25794193
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Approach to Anti-Cancer Drug Sensitivity Prediction.
Berlow N; Haider S; Wan Q; Geltzeiler M; Davis LE; Keller C; Pal R
IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(6):995-1008. PubMed ID: 26357038
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning of herbal compounds via a machine-learning approach.
Kim E; Choi AS; Nam H
BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
[TBL] [Abstract][Full Text] [Related]
20. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
